| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HUMANIGEN, INC | COO and CFO | Stock Option (Right to Buy) | 600K | $2.72M | $4.53 | Jul 27, 2022 | Direct |
| DBV Technologies S.A. | Director | Ordinary Shares | 12K | $20.9K | $1.74 | Aug 25, 2023 | Direct |
| Aquestive Therapeutics, Inc. | Director | Stock Option (right to purchase) | 38K | Jun 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| DBVT | DBV Technologies S.A. | Aug 25, 2023 | 1 | $18.2K | 4 | Aug 28, 2023 | Director |
| AQST | Aquestive Therapeutics, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| AQST | Aquestive Therapeutics, Inc. | Aug 16, 2022 | 1 | $0 | 4 | Aug 17, 2022 | Director |
| HGEN | HUMANIGEN, INC | Jul 27, 2022 | 1 | $0 | 4 | Jul 29, 2022 | COO and CFO |
| HGEN | HUMANIGEN, INC | Jan 12, 2022 | 1 | $0 | 4 | Jan 14, 2022 | COO and CFO |
| HGEN | HUMANIGEN, INC | Dec 31, 2021 | 1 | $0 | 4 | Jan 4, 2022 | COO and CFO |
| DBVT | DBV Technologies S.A. | Jun 10, 2021 | 1 | $48.7K | 4 | Jun 11, 2021 | Director |